Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| ID | DOID:3840 |
| Name | craniopharyngioma |
| Definition | |
| Source | DiseaseOntology.org |
| Alt Ids | |
| Path | disease disease of cellular proliferation benign neoplasm organ system benign neoplasm nervous system benign neoplasm central nervous system benign neoplasm craniopharyngioma |
| Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
|---|---|---|---|---|
| BRAF V600E | Dabrafenib + Trametinib | craniopharyngioma | predicted - sensitive | detail... |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT01964300 | Phase II | Peginterferon alfa-2b | Peginterferon Alfa-2b in Treating Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery | Terminated | USA | 0 |
| NCT05465174 | Phase II | Tovorafenib | Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults (PNOC029) | Recruiting | USA | AUS | 0 |
| NCT05525273 | Phase II | Dabrafenib + Trametinib | Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma (Swecranio) | Recruiting | SWE | 0 |